Ocular-vestibular Biomarker Identification for ADHD

Status unconfirmed

Conditions studied: ADHD - Combined Type, ADHD, ADHD Predominantly Inattentive Type, ADHD, Predominantly Hyperactive - Impulsive

In brief

This study intends to establish a relationship between oculovestibular eye tracking measures, measures of ADHD, and medication prescribed for ADHD.

Key facts

Study ID

NCT04504890

Run by

Sync-Think, Inc.

People needed

240

Starts

2020-07-16

Expected to finish

2021-10-05

Last updated by the study team

2020-10-23

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women ages 6-70 seeking evaluation and treatment for ADHD.

You may not qualify if…

• Clinical diagnosis of a neurological condition including the following: stroke, multiple sclerosis, epilepsy, brain tumor/cancer, dyslexia, nystagmus and/or other major neurological condition.
• Clinical diagnosis of any of the following eye-sight abnormalities: uncorrected amblyopia, uncorrected myopia, uncorrected presbyopia, uncorrected farsightedness or uncorrected Astigmatism.
• Psychiatric history with any of the following:
• LIFETIME: Clinical diagnosis of a psychotic disorder; bipolar disorder
• LAST YEAR: Clinical diagnosis of major depressive disorder; PTSD; clinical diagnosis of substance abuse disorder; major anxiety disorder
• Use of a psychotropic medication
• Impairment of cranial nerves II-VI
• Participants who receive a 'Poor' or 'Fair' eye tracking quality result on either their baseline or follow-up evaluations will be excluded from analysis. Subjects may not repeat participation

Where it is running

• Palo Alto Medical Foundation - San Carlos Center — San Carlos, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.